The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[4-(3-aminopropoxy)-3-bromophenyl]-N-[2-(4-chlorophenyl)ethyl]-2-hydroxyiminopropanamide hydrochloride ID: ALA537643
Max Phase: Preclinical
Molecular Formula: C20H24BrCl2N3O3
Molecular Weight: 468.78
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cl.NCCCOc1ccc(C/C(=N/O)C(=O)NCCc2ccc(Cl)cc2)cc1Br
Standard InChI: InChI=1S/C20H23BrClN3O3.ClH/c21-17-12-15(4-7-19(17)28-11-1-9-23)13-18(25-27)20(26)24-10-8-14-2-5-16(22)6-3-14;/h2-7,12,27H,1,8-11,13,23H2,(H,24,26);1H/b25-18-;
Standard InChI Key: PWSYEAWKFWMEHL-OYEQKBROSA-N
Molfile:
RDKit 2D
29 29 0 0 0 0 0 0 0 0999 V2000
7.6894 -2.2522 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2925 -3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2872 -4.9494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1872 -7.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4854 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9291 5.8600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4855 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7845 -10.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -8.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7846 -7.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1228 -10.3650 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 7 1 0
6 7 2 0
6 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
11 12 1 0
10 13 1 0
10 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
2 18 1 0
3 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
17 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
17 28 1 0
27 28 2 0
26 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.78Molecular Weight (Monoisotopic): 467.0611AlogP: 3.56#Rotatable Bonds: 10Polar Surface Area: 96.94Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.64CX Basic pKa: 9.96CX LogP: 2.79CX LogD: 1.76Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.21Np Likeness Score: -0.14
References 1. Zhu G, Yang F, Balachandran R, Höök P, Vallee RB, Curran DP, Day BW.. (2006) Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors., 49 (6): [PMID:16539395 ] [10.1021/jm051030l ]